title: Aspects of use of antimalarials in systemic lupus erythematosus.
authors.affiliation: University of Toronto, Centre for Prognosis Studies in The Rheumatic Diseases, The Toronto Hospital, Ontario.
authors.forename: D D
authors.initials: DD
authors.lastname: Gladman
authors.forename: M B
authors.initials: MB
authors.lastname: Urowitz
authors.forename: J L
authors.initials: JL
authors.lastname: Senécal
authors.forename: P J
authors.initials: PJ
authors.lastname: Fortin
authors.forename: R E
authors.initials: RE
authors.lastname: Petty
authors.forename: J M
authors.initials: JM
authors.lastname: Esdaile
authors.forename: S
authors.initials: S
authors.lastname: Carrette
authors.forename: S M
authors.initials: SM
authors.lastname: Edworthy
authors.forename: C D
authors.initials: CD
authors.lastname: Smith
authors.forename: J C
authors.initials: JC
authors.lastname: Thorne
mesh_terms: D000962:Antimalarials / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D017063:Outcome Assessment, Health Care; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy; D011792:Quebec; D012907:Smoking / Q000009:adverse effects
chemical_list: D000962:Antimalarials